Laboratorium Badań Genetycznych Lab4gensp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-05-09
Share capital
5,100.00 PLN
Registered address
ul. Kruszwicka 24/66, 53-659 Wrocław, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 1 of 6 financial statements not filed.

  • 2024not filed
  • 202308/07/2024
  • 202213/07/2023
  • 2021not filed
  • 202013/10/2021
  • 201909/10/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2023.

Division · Human health activities2,524 / 2,928
Top 86%
Top 86%
Voivodeship · Dolnośląskie34,373 / 41,332
Top 83%
Country · Poland412,497 / 495,860
Top 83%

Results vs industry

Revenue
This companyUSD 8.01kMedianUSD 91.71kAverageUSD 1.38m
Net profit
This companyUSD 1.71kMedianUSD 2.61kAverageUSD 145.69k
Operating costs
This companyUSD 6.13kMedianUSD 82.81kAverageUSD 1.18m
Assets
This companyUSD 7.87kMedianUSD 39.25kAverageUSD 949.40k

Authorized Representatives

Agnieszka Magdalena Pilecka – President of the Management Board

Manner of representation

Two members of the management board acting jointly are authorized to submit declarations of will on behalf of the company, and in the case of a one-person management board, the sole member of the management board acts independently.

Ownership

OwnerSharesShare valueStake
Andrzej Jerzy Kwaśnicaage 56
17$459.2133.3333%
Małgorzata Anna Masternakage 55
17$459.2133.3333%
Agnieszka Magdalena Pileckaage 46
17$459.2133.3333%

Beneficial owners

No beneficial owners recorded for the company Laboratorium Badań Genetycznych Lab4gen.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

Name
LabplusS.A.
WMC PietryszynS.K.A.
Kirei Clinicsp. z o.o.
Kmalkosp. z o.o.
8DT Klinikasp. z o.o.
Instytut Diagnostyki Molekularnej Diagmolsp. z o.o.
Kmnikosp. z o.o.
SMD Consultingsp. z o.o.
Esdent Diagnostykasp. z o.o.
Carina Caresp. z o.o.

FAQ

Last updated: 2026-04-07